Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Merrimack Pharmaceuticals Inc (MACK)

Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Merrimack Pharmaceuticals Inc ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 USA

www.merrimackpharma.com P: 617-720-8606

Description:

Merrimack Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery, development and preparation to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with a special focus on cancer. Merrimack Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 214,056
Enterprise Value, $K 208,066
Shares Outstanding, K 14,532
Annual Sales, $ 0 K
Annual Net Income, $ -1,180 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -240 K
EBIT, $ -2,040 K
EBITDA, $ -2,040 K
60-Month Beta 1.43
% of Insider Shareholders 28.87%
% of Institutional Shareholders 63.97%
Float, K 10,337
% Float 71.13%
Short Volume Ratio 0.51

Growth:

1-Year Return 20.87%
3-Year Return 108.94%
5-Year Return 149.66%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 98.24%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 03/07/24
Latest Earnings Date 05/02/24
Earnings Per Share ttm -0.08
EPS Growth vs. Prev Qtr 50.00%
EPS Growth vs. Prev Year 66.67%
Annual Dividend Yield 0.00%
Next Ex-Dividends Date 05/30/17
Dividend Payable Date 05/26/17
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 09/06/17

MACK Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -6.24%
Return-on-Assets % -6.09%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 11.24
Book Value/Share 1.31
Interest Coverage -0.43
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar